Andrew A. Radin & Andrew M. Radin
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
Startup Lightning Talks - 2022 MIT Health Science Technologies Conference: Innovations in Drug Discovery and Manufacturing
Startup Lightning Talks
Vincent Ling, Senior Director, Materials and Innovation, Takeda
Startup Lightning Talks presented at the 2024 MIT Tokyo Life Science Symposium.
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Looking for 6-8 startups to present their technology/products during the Startup Lightning Talks and participate in the Lunch Exhibit.